A recent study has found that higher serum levels of B-cell activating factor and anti-CCP3 are associated with a reduced risk of developing chronic lymphocytic leukemia (CLL), suggesting potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback